Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies
A new diagnosis of type 1 diabetes (T1D) may be accompanied by numerous lifelong financial, emotional, and physical challenges, thus advancements in therapies that can delay the onset of clinical disease are crucial. T1D is an autoimmune condition involving destruction of pancreatic beta cells leadi...
Saved in:
| Main Authors: | Alexander J. O’Donovan, Seth Gorelik, Laura M. Nally |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1477101/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibody Engineering Toward Enhancement of Teplizumab Anti-CD3 Binding Affinity in Type 1 Diabetes Prevention and Treatment
by: Fateme Sefid, et al.
Published: (2025-05-01) -
Teplizumab: a promising intervention for delaying type 1 diabetes progression
by: Muhammad Rizwan Saleem, et al.
Published: (2025-04-01) -
Innovations in Pharmacotherapy of Diabetes: A Review of Latest Reports
by: Katarzyna Czechowska, et al.
Published: (2025-07-01) -
The influence of intestinal microbiota on the development of type 1 diabetes
by: Katarzyna Augustowska, et al.
Published: (2024-11-01) -
Evaluation of anxiety condition among type 1 and type 2 diabetic patients
by: Bulut A, et al.
Published: (2016-10-01)